Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Cardio Diagnostics Holdings (CDIO) Equity Ratio (2021 - 2025)

Cardio Diagnostics Holdings' Equity Ratio history spans 5 years, with the latest figure at 0.93 for Q3 2025.

  • For Q3 2025, Equity Ratio rose 12.76% year-over-year to 0.93; the TTM value through Sep 2025 reached 0.93, up 12.76%, while the annual FY2024 figure was 0.9, 35.82% up from the prior year.
  • Equity Ratio for Q3 2025 was 0.93 at Cardio Diagnostics Holdings, down from 0.94 in the prior quarter.
  • Across five years, Equity Ratio topped out at 0.97 in Q4 2021 and bottomed at 0.01 in Q1 2022.
  • The 5-year median for Equity Ratio is 0.7 (2022), against an average of 0.61.
  • The largest annual shift saw Equity Ratio fell 28.98% in 2022 before it skyrocketed 3276.06% in 2023.
  • A 5-year view of Equity Ratio shows it stood at 0.97 in 2021, then fell by 28.98% to 0.69 in 2022, then dropped by 3.69% to 0.66 in 2023, then skyrocketed by 35.82% to 0.9 in 2024, then rose by 3.01% to 0.93 in 2025.
  • Per Business Quant, the three most recent readings for CDIO's Equity Ratio are 0.93 (Q3 2025), 0.94 (Q2 2025), and 0.93 (Q1 2025).